1. Home
  2. FHTX vs DMO Comparison

FHTX vs DMO Comparison

Compare FHTX & DMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

SELL

Current Price

$1.77

Market Cap

111.1M

Sector

Health Care

ML Signal

SELL

Logo Western Asset Mortgage Opportunity Fund Inc.

DMO

Western Asset Mortgage Opportunity Fund Inc.

SELL

Current Price

$9.33

Market Cap

108.8M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
FHTX
DMO
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
111.1M
108.8M
IPO Year
2020
2009

Fundamental Metrics

Financial Performance
Metric
FHTX
DMO
Price
$1.77
$9.33
Analyst Decision
Buy
Analyst Count
10
0
Target Price
★ $4.17
N/A
AVG Volume (30 Days)
★ 647.0K
57.0K
Earning Date
11-09-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 25.32
N/A
EPS
★ 0.43
N/A
Revenue
★ $30,909,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.17
★ N/A
Revenue Growth
★ 36.75
N/A
52 Week Low
$1.77
$9.29
52 Week High
$7.61
$12.05

Technical Indicators

Market Signals
Indicator
FHTX
DMO
Relative Strength Index (RSI) 33.34 36.55
Support Level N/A $9.29
Resistance Level $2.28 $9.74
Average True Range (ATR) 0.18 0.13
MACD 0.05 -0.04
Stochastic Oscillator 8.18 6.48

Price Performance

Historical Comparison
FHTX
DMO

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

About DMO Western Asset Mortgage Opportunity Fund Inc.

Western Asset Mortgage Defined Opportunity Fund Inc is a non-diversified, limited-term, closed-end management investment company. The fund's primary investment objective is to provide current income. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing in a diverse portfolio of mortgage-backed securities, consisting of non-agency residential mortgage-backed securities and commercial mortgage-backed securities.

Share on Social Networks: